chrX-102749506-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001142524.2(GPRASP3):c.511G>A(p.Glu171Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000174 in 1,210,331 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 5 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.0000089 ( 0 hom., 0 hem., cov: 23)
Exomes 𝑓: 0.000018 ( 0 hom. 5 hem. )
Consequence
GPRASP3
NM_001142524.2 missense
NM_001142524.2 missense
Scores
1
5
11
Clinical Significance
Conservation
PhyloP100: 1.82
Genes affected
GPRASP3 (HGNC:29353): (G protein-coupled receptor associated sorting protein family member 3) This gene is a member of a gene family which encodes proteins with a basic helix-loop-helix domain. Other members of this gene family encode proteins which function as transcription factors, either enhancing or inhibiting transcription depending on the activity of other DNA binding proteins. The coding region of this gene is located entirely within the terminal exon. The encoded protein may be involved in the survival of neurons (PMID: 15034937). Multiple alternatively spliced variants, encoding the same protein, have been identified. [provided by RefSeq, Sep 2011]
ARMCX5-GPRASP2 (HGNC:42000): (ARMCX5-GPRASP2 readthrough) This locus represents naturally occurring readthrough transcription among the adjacent armadillo repeat containing, X-linked 5 (ARMCX5), G protein-coupled receptor associated sorting proteins 1 and 2 (GPRASP1 and GPRASP2), basic helix-loop-helix family member b9 (BHLHB9), and long intergenic non-protein coding RNA 630 (LINC00630) genes on chromosome X. Transcripts may make use of multiple alternative promoters and polyadenylation signals in this region. Readthrough transcripts may produce proteins identical to the proteins encoded by GPRASP2 or BHLHB9. [provided by RefSeq, Apr 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.20830658).
BS2
High Hemizygotes in GnomAdExome4 at 5 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GPRASP3 | NM_001142524.2 | c.511G>A | p.Glu171Lys | missense_variant | 4/4 | ENST00000457056.6 | |
ARMCX5-GPRASP2 | NR_146584.3 | n.1218+28415G>A | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GPRASP3 | ENST00000457056.6 | c.511G>A | p.Glu171Lys | missense_variant | 4/4 | 4 | NM_001142524.2 | P1 | |
ARMCX5-GPRASP2 | ENST00000652409.1 | c.511G>A | p.Glu171Lys | missense_variant | 8/8 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000891 AC: 1AN: 112173Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34317
GnomAD3 genomes
AF:
AC:
1
AN:
112173
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
34317
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000709 AC: 13AN: 183257Hom.: 0 AF XY: 0.0000590 AC XY: 4AN XY: 67773
GnomAD3 exomes
AF:
AC:
13
AN:
183257
Hom.:
AF XY:
AC XY:
4
AN XY:
67773
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000182 AC: 20AN: 1098158Hom.: 0 Cov.: 32 AF XY: 0.0000138 AC XY: 5AN XY: 363512
GnomAD4 exome
AF:
AC:
20
AN:
1098158
Hom.:
Cov.:
32
AF XY:
AC XY:
5
AN XY:
363512
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000891 AC: 1AN: 112173Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34317
GnomAD4 genome
AF:
AC:
1
AN:
112173
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
34317
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
4
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 27, 2022 | The c.511G>A (p.E171K) alteration is located in exon 4 (coding exon 1) of the BHLHB9 gene. This alteration results from a G to A substitution at nucleotide position 511, causing the glutamic acid (E) at amino acid position 171 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T;T;T;T
FATHMM_MKL
Benign
N
LIST_S2
Benign
.;.;.;T;.
M_CAP
Uncertain
D
MetaRNN
Benign
T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;M;M;M;M
MutationTaster
Benign
N;N;N;N;N
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N;N;N
REVEL
Benign
Sift
Uncertain
D;D;D;D;D
Sift4G
Pathogenic
D;D;D;D;D
Polyphen
P;P;P;P;P
Vest4
MutPred
Gain of ubiquitination at E171 (P = 0.006);Gain of ubiquitination at E171 (P = 0.006);Gain of ubiquitination at E171 (P = 0.006);Gain of ubiquitination at E171 (P = 0.006);Gain of ubiquitination at E171 (P = 0.006);
MVP
MPC
0.12
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at